Stockreport

Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update

HEMISPHERX BIOPHARMA  (HEB) 
NASDAQ:AMEX Investor Relations: hemispherx.net/mobile/investor-relations.php
PDF ORLANDO, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), an advanced specialty pharmaceutical company engaged in the treatment o [Read more]